Hosted on MSN4d
CRISPR transforms ordinary fat cells into cancer killing machines
Cancer cells thrive in an environment deprived of oxygen and nutrients, adapting to survive and grow. Unlike normal cells, ...
Harvard Medical School9d
Creating the World’s First CRISPR Medicine, for Sickle Cell Disease
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
Engineering medicine: The future of CAR-T and CRISPR technologies
The future of medicine with CRISPR and CAR-T therapy, exploring ethical, societal, and accessibility challenges in healthcare ...
mRNA Vaccine Shows Promise In Pancreatic Cancer Trial
Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
Research upends scientific understanding of how anticancer drugs work
Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...
CRISPR Snips Away Extra Chromosomes, Offering New Hope for Down Syndrome Treatment
Scientists are exploring gene editing as a way to correct trisomy at the cellular level. Using CRISPR-Cas9, researchers ...
Cancer cells cooperate to scavenge for nutrients, scientists discover
Cancer cells work together to source nutrients from their environment—a cooperative process that was previously overlooked by ...
stocknews8d
3 Gene Therapy Stocks With Game-Changing Potential
Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...
Yahoo Finance13d
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
patient using CRISPR-based gene-editing therapy, Casgevy (exagamglogene autotemcel). This marks the first successful treatment of its kind outside the United States, positioning Bahrain as a ...
China Internet Information Center13d
Bahrain conducts 1st CRISPR-based sickle cell treatment outside U.S.
It marks the first successful treatment of its kind outside the United States, according to the institution. Casgevy, developed by Vertex Pharmaceuticals and CRISPR Therapeutics, is the world's ...